1. 2018
  2. An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer

    Matthias D'Huyvetter (Contributor), Jens De Vos (Contributor), Catarina Xavier (Contributor), Marek Pruszynski (Contributor), Yann Sterckx (Contributor), Sam Massa (Contributor), Geert Raes (Contributor), Vicky Caveliers (Contributor), Michaël Zalutsky (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Speaker)
    21 Mar 2018

    Activity: Talk or presentationTalk or presentation at a conference

  3. 2017
  4. Labeling an anti-HER2 VHH with 18F using a residualizing prosthetic group via strain-promoted click reaction: Preliminary evaluation

    Zhengyuan Zhou (Speaker), Nick Devoogdt (Contributor), Michaël Zalutsky (Contributor), Ganesan Vaidyanathan (Contributor)
    10 Jun 201714 Jun 2017

    Activity: Talk or presentationTalk or presentation at a conference

  5. International Francqui-Collen Inaugural Lecture: 'Targeted Radionuclide Therapy'

    Michaël Zalutsky (Speaker), Tony Lahoutte (Contributor)
    12 Jan 2017

    Activity: Talk or presentationTalk at an external academic organisation

ID: 74612